'Flexible' or 'lifestyle' dialysis: is this the way forward?
The flexible Geelong programme has been supported without exceeding the budget applied to a conventional dialysis programme with the same patient numbers.
These findings indicate that the presence of T cell-activating cytokines such as IL-7 or IL-15 in the joints of RA patients reduces the capacity of abatacept to inhibit MDC-driven CD4 T cell activation. This mechanism may be one explanation for the partial, and sometimes absent, response to abatacept therapy in a subset of patients.